Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 1, 2016, Pages 67-74

  Vidya, P ^a,b   Smith, L ^b   Beaudoin, T ^b   Yau, Y C W ^a,b   Clark, S ^a,c   Coburn, B ^d   Guttman, D S ^d,e   Hwang, D M ^a,c   Waters, V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; CANADA; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG TREATMENT FAILURE; ERADICATION THERAPY; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUORUM SENSING; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; GENE DELETION; GENETICS; ISOLATION AND PURIFICATION; LOCOMOTION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PSEUDOMONAS INFECTIONS; SECRETION (PROCESS); TREATMENT FAILURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CANADA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE DELETION; HUMANS; LOCOMOTION; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYSACCHARIDES, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING; TOBRAMYCIN; TREATMENT FAILURE;

EID: 84954393481     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2509-4     Document Type: Article

References (34)

1. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168(8):918–951
2. Pamukcu A, Bush A, Buchdahl R (1995) Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol 19(1):10–15
3. Henry RL, Mellis CM, Petrovic L (1992) Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12(3):158–161
4. Schelstraete P, Haerynck F, Van Daele S, Deseyne S, De Baets F (2013) Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa. J Cyst Fibros 12(1):1–8
5. Levy H, Kalish LA, Cannon CL et al (2008) Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol 43(5):463–471
6. Mayer-Hamblett N, Kronmal RA, Gibson RL et al (2012) Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol 47(2):125–134
7. Douglas TA, Brennan S, Gard S et al (2009) Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J 33(2):305–311
8. Manos J, Hu H, Rose BR et al (2013) Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. Eur J Clin Microbiol Infect Dis 32(12):1583–1592
9. Tramper-Stranders GA, van der Ent CK, Molin S et al (2012) Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. Clin Microbiol Infect 18(6):567–574
10. Mayer-Hamblett N, Ramsey BW, Kulasekara HD et al (2014) Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis. Clin Infect Dis 59(5):624–631
11. Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326(18):1187–1191
12. Stanojevic S, Waters V, Mathew JL, Taylor L, Ratjen F (2014) Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis. J Cyst Fibros 13(2):172–178
13. Ratjen F, Munck A, Kho P, Angyalosi G; ELITE Study Group (2010) Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 65(4):286–291
14. Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N et al (2011) Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 165(9):847–856
15. de la Fuente-Núñez C, Korolik V, Bains M et al (2012) Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 56(5):2696–2704
16. Sokol PA, Ohman DE, Iglewski BH (1979) A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa. J Clin Microbiol 9(4):538–540
17. Zlosnik JE, Hird TJ, Fraenkel MC, Moreira LM, Henry DA, Speert DP (2008) Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol 46(4):1470–1473
18. O’Toole GA (2011) Microtiter dish biofilm formation assay. J Vis Exp (47). pii: 2437
19. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. CLSI document M100-S22. CLSI, Wayne, PA
20. Dekimpe V, Déziel E (2009) Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology 155(Pt 3):712–723
21. Schaber JA, Carty NL, McDonald NA et al (2004) Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 53(Pt 9):841–853
22. Hogardt M, Heesemann J (2010) Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300(8):557–562
23. Ranganathan SC, Skoric B, Ramsay KA et al (2013) Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann Am Thorac Soc 10(2):108–114
24. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB (2012) Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 7(9):e44199
25. Kosorok MR, Jalaluddin M, Farrell PM et al (1998) Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 26(2):81–88
26. Mayer-Hamblett N, Kloster M, Rosenfeld M et al (2015) Impact of sustained eradication of new Pseudomonas aeruginosa infection on long-term outcomes in cystic fibrosis. Clin Infect Dis 61(5):707–715
27. Li Z, Kosorok MR, Farrell PM et al (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293(5):581–588
28. Chmiel JF, Aksamit TR, Chotirmall SH et al (2014) Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc 11(7):1120–1129
29. Guttenplan SB, Kearns DB (2013) Regulation of flagellar motility during biofilm formation. FEMS Microbiol Rev 37(6):849–871
30. Carfartan G, Gerardin P, Turck D, Husson MO (2004) Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients. J Antimicrob Chemother 53(4):686–688
31. Bjarnsholt T, Jensen PØ, Jakobsen TH et al (2010) Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 5(4):e10115
32. D’Argenio DA, Wu M, Hoffman LR et al (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64(2):512–533
33. Wang S, Yu S, Zhang Z et al (2014) Coordination of swarming motility, biosurfactant synthesis, and biofilm matrix exopolysaccharide production in Pseudomonas aeruginosa. Appl Environ Microbiol 80(21):6724–6732
34. Colvin KM, Irie Y, Tart CS et al (2012) The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol 14(8):1913–1928